XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income (loss) $ 9,202,000 $ 11,157,000 $ (1,913,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 5,171,000 5,749,000 6,524,000
Deferred income tax expense (benefit) 935,000 195,000 (545,000)
Impairment of intangible assets     5,149,000
Amortization of deferred costs 10,000 37,000 40,000
Compensation expense related to restricted stock awards 1,858,000 1,335,000 2,221,000
(Gain) loss on sale of assets, net (14,000) 7,000 (1,247,000)
(Gain) on insurance claims (534,000) (589,000) (233,000)
Other (gain) loss, net (118,000) (45,000)  
Barter (revenue) expense, net 46,000 (2,000) (133,000)
Deferred and other compensation 1,425,000 (215,000) 463,000
Changes in assets and liabilities:      
(Increase) decrease in receivables and prepaid expenses (1,135,000) 507,000 3,016,000
Increase (decrease) in accounts payable, accrued expenses, and other liabilities 279,000 968,000 (1,254,000)
Total adjustments 7,923,000 7,947,000 14,001,000
Net cash provided by operating activities 17,125,000 19,104,000 12,088,000
Cash flows from investing activities:      
Purchase of Short-term investments (18,000,000)    
Redemption of Short-term investments 8,000,000    
Acquisition of property and equipment (5,994,000) (3,969,000) (2,314,000)
Acquisition of broadcast properties (57,000) (150,000) (190,000)
Proceeds from sale and disposal of assets 411,000 142,000 1,691,000
Proceeds from insurance claims 534,000 589,000 233,000
Other investing activities 116,000 40,000 (24,000)
Net cash used in investing activities (14,990,000) (3,348,000) (604,000)
Cash flows from financing activities:      
Payments on long-term debt   (10,000,000)  
Cash dividends paid (19,785,000) (1,914,000) (3,716,000)
Payments for debt issuance costs (161,000)    
Purchase of treasury shares (147,000) (435,000) (449,000)
Net cash used in financing activities (20,093,000) (12,349,000) (4,165,000)
Net increase (decrease) in cash and cash equivalents (17,958,000) 3,407,000 7,319,000
Cash and cash equivalents, beginning of period 54,760,000 51,353,000 44,034,000
Cash and cash equivalents, end of period $ 36,802,000 $ 54,760,000 $ 51,353,000